메뉴 건너뛰기
Arthritis and Rheumatism
Volumn 62, Issue 11, 2010, Pages 3514-3515
Reply
Author keywords

[No Author keywords available]
Indexed keywords

ANTIRHEUMATIC AGENT; DIPEPTIDE; DIPEPTIDYL PEPTIDASE; DIPEPTIDYL PEPTIDASE 8; DIPEPTIDYL PEPTIDASE 9; DIPEPTIDYL PEPTIDASE IV; INTERSTITIAL COLLAGENASE; PT 630; SEPRASE; STROMAL CELL DERIVED FACTOR 1; STROMELYSIN; TALABOSTAT; UNCLASSIFIED DRUG;
EID: 78249279384     PISSN: 00043591     EISSN: 15290131     Source Type: Journal    
DOI: 10.1002/art.27675     Document Type: Letter
Times cited : (1)
References (5)
  • 1
    • 46749104496 scopus 로고    scopus 로고
    • On the edge of validation: Cancer protease fibroblast activation protein
    • Wolf B, Clifford Q, Tran T, Wiesmann C, Sutherlin D,. On the edge of validation: cancer protease fibroblast activation protein. Med Chem 2008; 8: 719 - 27.
    • (2008) Med Chem , vol.8 , pp. 719-27
    • Wolf, B.1    Clifford, Q.2    Tran, T.3    Wiesmann, C.4    Sutherlin, D.5
  • 2
    • 72849125358 scopus 로고    scopus 로고
    • Targeting fibroblast activation protein inhibits tumor stromagenesis and growth in mice
    • Santos AM, Jung J, Aziz N, Kissil JL, Pure E,. Targeting fibroblast activation protein inhibits tumor stromagenesis and growth in mice. J Clin Invest 2009; 119: 3613 - 25.
    • (2009) J Clin Invest , vol.119 , pp. 3613-25
    • Santos, A.M.1    Jung, J.2    Aziz, N.3    Kissil, J.L.4    Pure, E.5
  • 3
    • 72849121090 scopus 로고    scopus 로고
    • Inhibitors of the stromal protease fibroblast activation protein attenuate tumor growth in vivo
    • abstract
    • Narra K, Lee HO, Lerro A, Valvardi J, Azeez O, Jesson M, et al. Inhibitors of the stromal protease fibroblast activation protein attenuate tumor growth in vivo [abstract]. Proc Am Assoc Cancer Res 2006; 47: 4382.
    • (2006) Proc Am Assoc Cancer Res , vol.47 , pp. 4382
    • Narra, K.1    Lee, H.O.2    Lerro, A.3    Valvardi, J.4    Azeez, O.5    Jesson, M.6
  • 4
    • 20444421293 scopus 로고    scopus 로고
    • Fibroblast activation protein and dipeptidyl peptidase IV (CD26): Cell surface proteases that activate cell signalling and are potential targets for cancer therapy
    • Kelly T,. Fibroblast activation protein and dipeptidyl peptidase IV (CD26): cell surface proteases that activate cell signalling and are potential targets for cancer therapy. Drug Resist Updat 2005; 8: 51 - 8.
    • (2005) Drug Resist Updat , vol.8 , pp. 51-8
    • Kelly, T.1
  • 5
    • 41849147200 scopus 로고    scopus 로고
    • Phase II trial of single agent Val-boroPro (Talabostat) inhibiting fibroblast activation protein in patients with metastatic colorectal cancer
    • Narra K, Mullins SR, Lee HO, Strzemkowski-Brun B, Magalong K, Christiansen VJ, et al. Phase II trial of single agent Val-boroPro (Talabostat) inhibiting fibroblast activation protein in patients with metastatic colorectal cancer. Cancer Biol Ther 2007; 6: 1691 - 9.
    • (2007) Cancer Biol Ther , vol.6 , pp. 1691-1699
    • Narra, K.1    Mullins, S.R.2    Lee, H.O.3    Strzemkowski-Brun, B.4    Magalong, K.5    Christiansen, V.J.6

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.